Ъѹ
TH EN
Ъѹ

 


ǽҡ >> Ԩ
NICE ʹѺʹعǷҧ㹡ѡҼä秵Ѻ

ѹ 31 .. 2556 )
 
         ǷҧҡҪҳҨѡèЪä秵ѺҶ֧ѡҴ SIR-Spheres(R) microspheres ҡ

          ʶҺѹȷҧԹԡآҾ觪ҵԢͧҪҳҨѡ (NICE) ǷҧʹѺʹعúӺѴ¡ùѧҧ੾Шش (SIRT) Ըջ㹡ѡҼä秵Ѻ[1] õѴԹ㨴ѧ繢ǴѺä秵Ѻ鹪Դ辺·ش¡ hepatocellular carcinoma HCC Ըѡҷ§Ը㹻Ѩغѹ

          SIRT Ըѡ秵ѺöҵѴ ¡éմ͹Ҥѹѧ microsphere ҴҹѺҹҧʹʹᴧѺ microsphere еǶ١ͺ yttrium-90 ⷻѹѧշŴѧີ͡ ѧըҷ੾ШشѺѧ SIR-Spheres microspheres SIRT ٻẺ˹ ҹѺͧû㹻 2545 ж١ѡҡ 35,000 駷š ռ¡ 500 ѧɷѺѡҴԸչ Ƿҧͧ NICE ѹ 24 áҤ 2556 ׹ѹѡҹʹлԷҾͧ SIRT 㹡ѡҼä HCC § ¤Ҽ·ԷѡСѹآҾ觪ҵԢͧѧ (NHS) ҨҶ֧ѡҴԸչҡ

          .շ ѹ (Dr Harpreet Wasan) ֡ҴҹԷҨҡçԸ Է

          "SIRT Ըշѹ㹡ѡҼä秵Ѻ鹷ҵѴ Ըѡҷ§Ը 繷Թշ NICE ǷҧʹѺʹعѡҹش㹡 SIRT ѡä HCC 觷Ҽ¨Ҷ֧ SIRT ҹкСѹآҾ觪ҵ ѧҡѡẺͧҵðҹСѡҷҪТ鹵͹ԡ͹ѵԤѡҾҺŷԹҹҹ 繻ѭѺ·ԷѡСѹآҾ觪ҵԷѺѡҴ SIRT ա仔

          ǡѺä秵Ѻ hepatocellular carcinoma HCC

          HCC Դ㹼·Ѻ١ҧ˹ѡҡõѺ ѡ繼ҨҡäѺҧ µԴʵѺѡʺ͵Ѻ١дš HCC 1 10 Դ辺ҡشš ռ·ѺԹԨͺ 750,000 µͻ 秷ҪԵҡѹѺ㹺ôä秷[2] HCC ·ش㹾鹷ԹԨ¾ʵѺѡʺҡش ҧừԿԡû

          HCC öѡ¡üҵѴҹ Ẻ͹͵Ѵ͵Ѻǹ͡ ͻ١µѺҡԨҤ ҧá üҵѴԸշѺǹ˭ ͡ժԵ§ 2-3 ͹仨֧ ѺҾͧѺѺԹԨТͺࢵءͧ

         

          SIR-Spheres microspheres Ѻ͹حҵ, Ҿû (ҵðҹ CE), ǫŹ, ԵŹ, á ա» Ѻѡä秵Ѻ͹·

          ͡ҡ SIR-Spheres microspheres ѧҹѺͧ FDA PMA Ѱԡ ѡä秵Ѻءҡ˭мҵѴ͹ Ѻ÷պӺѴʹʹᴧѺ floxuridine

          (R)SIR-Spheres ͧ¡äҨ¹ͧѷ Sirtex SIR-Spheres Pty Ltd

          ҧԧ

          1. National Institute for Health and Clinical Excellence. Selective internal radiation therapy for primary hepatocellular carcinoma (Interventional Procedure Guidance 460). London: NICE, July 2013.
          2. GLOBOCAN. Liver Cancer Incidence and Mortality Worldwide in 2008.

          732-EUA-0713

          觢: Sirtex Medical Limited



ǡѺ

  • ѵ
  • ҷ˹ҷ
  • ·ȹ
  • Һó
  • ˹§ҹ
  • ˹§ҹ

  • ʶҹ÷ȹ

  • 䫵ʶҹԷ÷ȹ
  • ÷ȹЪѹ

    ʶҹԷ

  • 䫵ʶҹԷءШ§

  • ѧԷءЪѹ

  • ԡâͧЪѹ

    line Ъѹ
     


    © ʧǹԢԷ Ъѹ Ţ 9 .ѹ . 6 ǧ ࢵ ا෾ 10400
    Ѿҧ : 02-6182323 Ҵ:51274 : 02-6182364,02-6182399 E-mail webmaster@prd.go.th
    Facebook Twitter Barcode